Skip to content
Open access · CC-BY via OpenAlex

Rapamycin, proliferation and geroconversion to senescence

Mikhail V. Blagosklonny

Cell Cycle · 2018 · ▲ 65 citations

Abstract

mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) inhibits cell proliferation, yet preserves (re)-proliferative potential (RPP). RPP is a potential of quiescent cells that is lost in senescent cells. mTOR drives conversion from quiescence to senescence(definition) (geroconversion). By suppressing geroconversion, rapamycin preserves RPP. Geroconversion is characterized by proliferation-like levels of phospho-S6K/S6/4E-BP1 in nonproliferating cells arrested by p16 and/or p21. mTOR-driven geroconversion is associated with cellular hyperfunction, which in turn leads to organismal aging manifested by age-related diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1080/15384101.2018.1554781
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Blagosklonny, M.V. (2018). Rapamycin, proliferation and geroconversion to senescence. <em>Cell Cycle</em>. https://doi.org/10.1080/15384101.2018.1554781
Vancouver
Blagosklonny MV. Rapamycin, proliferation and geroconversion to senescence. Cell Cycle. 2018. doi:10.1080/15384101.2018.1554781.
BibTeX
@article{mikhail2018Rapamy, title = {Rapamycin, proliferation and geroconversion to senescence}, author = {Mikhail V. Blagosklonny}, journal = {Cell Cycle}, year = {2018}, doi = {10.1080/15384101.2018.1554781}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings